Skip to main content

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Terminated · Phase 3 · NCT04396236

Conditions: Migraine

At a glance

Research payments reported, 2025
$566,672
U.S. investigators named
63
Sites paid
65
Planned or actual enrollment
847

About the trial

Sponsor
Eli Lilly and Company
Tested
Lasmiditan (drug), Placebo (drug)
Dates
Started 2020-06-15; completion 2025-11-12
Results posted
Yes

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

From ClinicalTrials.gov, last updated 2026-09-02. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $566,672 in research payments for this study in 2025 (107 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Medical Research PArtners $65,009
  • Cincinnati Children's Hospital Medical Center, OH $51,401
  • Ezy Medical Research Co $47,157
  • Ohsu Hospital and Clinics, OR $31,383
  • Pediatric Neurology PA $24,993
  • Frontier Clinical Research LLC $24,270
  • Velocity Clinical Research Inc $23,743
  • Chicago Headache Center $23,162
  • Sky Clinical Research Network Group $22,871
  • Deaconess Clinic Inc $19,014
  • Elligo Health Research Inc $17,120
  • Allied Physicians Inc DBA Fort Wayne Neurological Center $16,958
  • Eastside Therapeutic Resource Inc $16,515
  • Rehabilitation & Neurological Services, Ll $14,868
  • Children's Hospital Colorado, CO $13,448
  • Clinvest Headlands LLC $11,874
  • Clinical Neuroscience Solutions DBA Cns Hlthcare $11,625
  • Yale University $10,842
  • Seattle Children's Hospital, WA $10,640
  • Puerto Rico Health and Wellness Institute $9,576
  • Great Lakes Research Group Inc $9,574
  • Clinpoint Trials LLC $8,482
  • Northwest Clinical Research Center $6,832
  • Childrens Hospital, LA $6,695
  • Alliance for Multispecialty Research Lls $6,000
  • Qualmedica Research LLC $5,940
  • University of Miami $5,178
  • Hawaii PAcific Neuroscience LLC $4,749
  • Alexian Brothers Hospital Network $4,694
  • Suncoast Clinical Research $4,631
  • Neurology Associates of Tucson $3,986
  • Integrated Clinical Trial Services Inc $3,707
  • Arkansas Childrens Hospital $2,200
  • Memorial Health Services $2,190
  • Tribe Clinical Research LLC $2,068
  • Dr Samuel Sanchez Psc $1,796
  • Ponce School of Medicine $1,596
  • Wellness Clinical Research LLC $1,533
  • Pensacola Research Consultants Inc $1,255
  • Univ of South Florida Rsrch Foundation $1,238
  • Clinvest Research LLC $1,208
  • Hope L. O'brien $975
  • Wake Research Associ $973
  • Long Beach Ctr for Clinical Research $899
  • Monroe Biomedical Research $858
  • Clinedge LLC $852
  • Josephson Wallack Munshower Neurology $846
  • California Research Trials $821
  • Puerto Rico Health Institute LLC $784
  • Center for Dermatology and Plastic Surgery $747
  • Jkpc LLC DBA Sensa Health Clinical Research $690
  • Minneapolis Clinic of Neurology $674
  • University of Kentucky Hospital, KY $596
  • Houston Neurology Clinical and Diagnostic Consultants Co $596
  • Pcrs Network LLC $596
  • Care Access Research LLC $596
  • Emory University Hospital, GA $596
  • Desert Medical Advances $596
  • Corvallis Clinic PC $505
  • Phoenix Children's Hospital, AZ $500
  • New Horizon Research Center $485
  • Omega Research Consultants LLC $367
  • Deaconess Hospital Inc, IN $50
  • St Josephs Hospital and Medical Center $50
  • Ki Health PArtners LLC $6

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.